Disc Medicine Set to Participate in Key Investor Conferences
Disc Medicine, Inc. (NASDAQ:IRON) is gearing up to take part in several important investor conferences. As a clinical-stage biopharmaceutical company, they are committed to tackling serious hematologic diseases with innovative treatments. These conferences offer a prime opportunity for the company to connect with investors and showcase their progress.
Conference Participation Details
The management team will engage in a series of fireside chats at prominent investor conferences. Here are some key details about these upcoming events:
Wells Fargo Securities Healthcare Conference
Disc Medicine will begin their conference schedule at the 2024 Wells Fargo Securities Healthcare Conference, taking place on a Friday in September. The management is scheduled to present at 10:15 a.m. ET, providing a crucial chance for attendees to learn about the company’s initiatives and future plans.
Morgan Stanley Global Healthcare Conference
Following the Wells Fargo event, the company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference later that same day. This session is set for 1:05 p.m. ET, aimed at reaching a broader audience and offering essential insights into their ongoing projects.
H.C. Wainwright Annual Global Investment Conference
Next on the agenda is the H.C. Wainwright 26th Annual Global Investment Conference, where the company will present on a Wednesday in September at 9:30 a.m. ET. Investors can look forward to updates on the latest developments and the company’s strategies for navigating the biopharmaceutical landscape.
Cantor Global Healthcare Conference
Disc Medicine will wrap up their conference participation with a session at the 2024 Cantor Global Healthcare Conference, scheduled for Thursday at 8:00 a.m. ET. Each of these conferences underscores Disc Medicine's commitment to transparency and open communication with the investment community.
Live Webcast Access
For those who wish to follow the discussions but cannot attend in person, a live webcast will be available through the investor relations section of their website. This allows interested parties to stay informed remotely. Additionally, an archived replay will be accessible for further insights after the events.
Disc Medicine’s Mission Explained
Disc Medicine (NASDAQ:IRON) is dedicated to developing solutions for patients suffering from serious hematologic diseases. The company is working on a portfolio of innovative therapeutic candidates that target key biological pathways associated with red blood cell biology. Their focus includes addressing heme biosynthesis and iron homeostasis, which could lead to significant advancements in treating various blood disorders.
Contact Information for Inquiries
For media inquiries, Peg Rusconi from the Deerfield Group can be contacted at peg.rusconi@deerfieldgroup.com. Investors seeking more comprehensive information about the company’s financials can reach out to Christina Tartaglia from Precision AQ at christina.tartaglia@precisionaq.com.
Frequently Asked Questions
What is the focus of Disc Medicine?
Disc Medicine specializes in discovering and developing innovative treatments for serious hematologic diseases.
When will the conferences take place?
The conferences are scheduled throughout September, specifically on the 6th, 11th, and 19th.
How can I watch the presentations?
A live webcast will be accessible on the investor relations section of the company's website.
Who can I contact for media inquiries?
Peg Rusconi from Deerfield Group is available to address any media-related questions.
What is NASDAQ:IRON?
NASDAQ:IRON is the stock ticker symbol for Disc Medicine, which investors use to monitor its performance on the stock market.